Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|August 22, 2001
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonistsJ Witherington, V Bordas, D G Cooper, et al.Acta Crystallographica. Section B, Structural Science|April 1, 1994
Structures of histamine H1-receptor antagonists derived from the cimetidine group of histamine H2-receptor antagonistsC Bannister, K Burns, K Prout, et al.Applied Optics|September 11, 2010
Mid-IR absorption in AgGaSe(2) optical parametric oscillator crystalsG C Catella, L R Shiozawa, J R Hietanen, et al.British Journal of Pharmacology|January 1, 1991
Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptorJ E Merritt, T J Hallam, A M Brown, et al.British Journal of Pharmacology|January 1, 1991
Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptorJ E Merritt, A M Brown, S Bund, et al.Bioorganic & Medicinal Chemistry Letters|September 2, 2000
CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compoundI T Forbes, D G Cooper, E K Dodds, et al.New England and Regional Allergy Proceedings|March 1, 1986
Icotidine, an antagonist of histamine at both H1 and H2 receptorsC R Ganellin, R C Blakemore, T H Brown, et al.Neuropharmacology|November 1, 1993
SB 201823-A, a neuronal Ca2+ antagonist is neuroprotective in two models of cerebral ischaemiaC D Benham, T H Brown, D G Cooper, et al.Chemistry & Biology|October 27, 2007
A class of small molecules that inhibit TNFalpha-induced survival and death pathways via prevention of interactions between TNFalphaRI, TRADD, and RIP1Tarikere L Gururaja, Stephanie Yung, Rongxian Ding, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
R-253 disrupts microtubule networks in multiple tumor cell linesTarikere L Gururaja, Dane Goff, Taisei Kinoshita, et al.Pageof 8